tiprankstipranks
Trending News
More News >
Standard BioTools (LAB)
NASDAQ:LAB

Standard BioTools (LAB) Stock Statistics & Valuation Metrics

Compare
452 Followers

Total Valuation

Standard BioTools has a market cap or net worth of $451.99M. The enterprise value is $112.96M.
Market Cap$451.99M
Enterprise Value$112.96M

Share Statistics

Standard BioTools has 379,822,270 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding379,822,270
Owned by Insiders24.16%
Owned by Institutions49.20%

Financial Efficiency

Standard BioTools’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -31.48%.
Return on Equity (ROE)-0.29
Return on Assets (ROA)-0.23
Return on Invested Capital (ROIC)-31.48%
Return on Capital Employed (ROCE)-0.32
Revenue Per Employee214.29K
Profits Per Employee-170.62K
Employee Count814
Asset Turnover0.28
Inventory Turnover2.21

Valuation Ratios

The current PE Ratio of Standard BioTools is -4.45. Standard BioTools’s PEG ratio is >-0.01.
PE Ratio-4.45
PS Ratio0.00
PB Ratio-1.12
Price to Fair Value1.31
Price to FCF-0.98
Price to Operating Cash Flow-1.03
PEG Ratio>-0.01

Income Statement

In the last 12 months, Standard BioTools had revenue of 174.43M and earned -138.88M in profits. Earnings per share was -0.52.
Revenue174.43M
Gross Profit84.26M
Operating Income-175.24M
Pretax Income-138.31M
Net Income-138.88M
EBITDA-118.14M
Earnings Per Share (EPS)-0.52

Cash Flow

In the last 12 months, operating cash flow was -111.26M and capital expenditures -12.63M, giving a free cash flow of -123.89M billion.
Operating Cash Flow-111.26M
Free Cash Flow-123.89M
Free Cash Flow per Share-0.33

Dividends & Yields

Standard BioTools pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.38
52-Week Price Change-31.21%
50-Day Moving Average1.11
200-Day Moving Average1.50
Relative Strength Index (RSI)55.79
Average Volume (3m)2.17M

Important Dates

Standard BioTools upcoming earnings date is Aug 6, 2025, After Close (Confirmed).
Last Earnings DateMay 6, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date

Financial Position

Standard BioTools as a current ratio of 5.70, with Debt / Equity ratio of -126.01%
Current Ratio5.70
Quick Ratio5.09
Debt to Market Cap0.01
Net Debt to EBITDA1.13
Interest Coverage Ratio-52.85

Taxes

In the past 12 months, Standard BioTools has paid 573.00K in taxes.
Income Tax573.00K
Effective Tax Rate>-0.01

Enterprise Valuation

Standard BioTools EV to EBITDA ratio is -4.10, with an EV/FCF ratio of -3.19.
EV to Sales2.78
EV to EBITDA-4.10
EV to Free Cash Flow-3.19
EV to Operating Cash Flow-3.38

Balance Sheet

Standard BioTools has $258.06M in cash and marketable securities with $31.53M in debt, giving a net cash position of -$226.53M billion.
Cash & Marketable Securities$258.06M
Total Debt$31.53M
Net Cash-$226.53M
Net Cash Per Share-$0.60
Tangible Book Value Per Share$0.94

Margins

Gross margin is 37.83%, with operating margin of -100.46%, and net profit margin of -79.62%.
Gross Margin37.83%
Operating Margin-100.46%
Pretax Margin-79.29%
Net Profit Margin-79.62%
EBITDA Margin-67.73%
EBIT Margin-77.39%

Analyst Forecast

The average price target for Standard BioTools is $2.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.50
Price Target Upside110.08% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast33.86%
EPS Growth Forecast64.34%

Scores

Smart Score2
AI Score56
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis